Cooperation Creates Broad Portfolio at Best Market Price

Dr. Bernd Soyke, CEO, Penta
Dr. Bernd Soyke, CEO, Penta

What kind of growth do you aspire to in the next few years?

We expect organic growth through expansion of our customer and product portfolio as well as offering new services to our customers.

In which sectors, markets or regions do you see significant growth opportunities?

Generally, we see opportunities in all sectors where we are active. As a cooperation network with focus on the European chemical distribution segment, we have growth opportunities in many different regions, markets and sectors.

How do you intend to implement these plans and seize these opportunities?

Penta takes its chances out of the cooperation. Our shareholding companies as well as our cooperation partners form a strong alliance in order to offer our customers a broad product and service portfolio in virtually every place in Europe at the best market price possible. This has been our success factor for almost 50 years.

 

Company

Penta Chemikalien GmbH & Co.KG


Mainaschaff
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.